Weinberg Uri

Insider Reports History

Entity
Individual
Location
Novocure Inc., 20 Valley Stream Parkway, Suite 300, Malvern, PA
Signature
Steven Robbins, as attorney in fact for Weinberg, Uri
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Weinberg Uri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Innovation Officer Ordinary Shares 221K $4.02M $18.19 Mar 4, 2025 Direct
NovoCure Ltd Chief Innovation Officer Stock Options (Right to buy) 81.5K $1.48M $18.19 Mar 4, 2025 Direct

Insider Reports Filed by Weinberg Uri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVCR NovoCure Ltd Mar 4, 2025 2 $2.48M 4 Mar 6, 2025 Chief Innovation Officer
NVCR NovoCure Ltd Mar 3, 2025 1 -$5.07K 4 Mar 4, 2025 Chief Innovation Officer
NVCR NovoCure Ltd Mar 3, 2025 2 -$86.9K 4/A Mar 3, 2025 Chief Innovation Officer
NVCR NovoCure Ltd Feb 28, 2025 2 -$86.9K 4 Mar 3, 2025 Chief Innovation Officer
NVCR NovoCure Ltd Feb 27, 2024 2 $3.37M 4 Feb 29, 2024 Chief Innovation Officer
NVCR NovoCure Ltd Jun 30, 2023 1 $10.8K 4 Jul 6, 2023 Chief Innovation Officer
NVCR NovoCure Ltd Mar 3, 2023 2 $0 4 Mar 6, 2023 Chief Innovation Officer
NVCR NovoCure Ltd Feb 28, 2023 2 $1.66M 4 Mar 2, 2023 Chief Innovation Officer
NVCR NovoCure Ltd Jan 5, 2023 6 -$854K 4 Jan 9, 2023 Chief Science Officer
NVCR NovoCure Ltd Jul 5, 2022 1 $16.6K 4 Jul 7, 2022 Chief Science Officer
NVCR NovoCure Ltd Mar 3, 2022 3 $2.85M 4 Mar 7, 2022 Chief Science Officer
NVCR NovoCure Ltd Jan 6, 2022 1 $2.23K 4 Jan 12, 2022 Chief Science Officer
NVCR NovoCure Ltd Jul 6, 2021 1 $15.5K 4 Jul 8, 2021 Chief Science Officer
NVCR NovoCure Ltd May 10, 2021 4 -$889K 4 May 12, 2021 Chief Science Officer